Skip to main content

Table 2 Musculoskeletal symptoms

From: Musculoskeletal symptoms in SARS-CoV-2 (COVID-19) patients

Study (year)No. of patientsFatigue (nr/%)Arthralgia/Myalgia (nr/%)
Zheng et al. [37]9972 (73%)12 (12%)
Lei et al. [36]3425 (73.5%)11 (32.4%)
Mo et al. [60]15560 (73.2)50 (61.0%)
Qian et al. [61]9140 (43.96%)5 (5.49%)
Ma et al. [62]374 (10.8%)4 (10.8%)
Jin et al. [10]651119 (18.2%)/
Zheng et al. [11]16164 (39.8%)18 (11.2%)
Wang et al. [12]8028 (35%)19 (23.75%)
Chen et al. [13]20316 (7.9%)54 (26.6)
Zhou et al. [14]215 (23.8%)2 (9.5%)
Lo et al. [15]10/3 (30%)
Huang et al. [16]4118 (44%)/
Zhang et al. [17]645118 (18.3%)71 (11%)
Chen et al. [18]24939 (15.7%)/
Feng et al. [19]476/59 (12.4%)
Chen et al. [20]274137 (50%)60 (22%)
Zhang et al. [58]140105 (75%)/
Lian et al. [47]788139 (17.6%)91 (11.5%)
Cai et al. [21]29813 (4.3%)/
Wan et al. [22]135/44 (32.5%)
Cao et al. [9]10256 (54.9%)35 (34.3)
Wang et al. [32]339135 (39.9%)16 (4.7%)
Xu et al. [26]62/32 (52%)
Zhou et al. [27]19144 (23%)29 (15%)
Wu et al. [29]20165 (32.3%)/
Du et al. [33]8550 (58.8%)14 (16.5%)
Wang et al. [35]6929 (42%)21 (30%)
Guan et al. [33]1099419 (38%)164 (15%)
Goyal et al. [46]393/94 (24%)
Zhang et al. [24]2818 (64%)4 (14%)
Chen et al. [34]11819 (16%)/
Wang et al. [41]1012/170 (17%)
Xia et al. [38]103 (30%)/
Liang et al. [39]1590680 (43%)278 (17%)
Dai et al. [40]23431 (13%)21 (9%)
Li et al. [41]2517 (68%)/
Chu et al. [42]549 (17%)3 (6%)
Qi et al. [43]70/12 (17%)
Godaert et al. [7]1710 (59%)/
Ye et al. [28]55 (100%)/
Huang et al. [44]225 (23%)4 (18%)
Tian et al. [45]26269 (26%)/
Huang et al. [8]34/22 (65%)
Xia et al. [48]201 (5%)/
Zhao et al. [49]101/17 (17%)
Xu et al. [25]512 (4%)8 (16%)
Li et al. [51]548258 (47%)111 (20%)
Xu et al. [52]9019 (21%)25 (28%)
Lei et al. [54]119/18 (15%)
Pung et al. [6]17/5 (29%)
Xu et al. [55]508 (16%)8 (16%)
Escalera-Antezana et al. [59]12/5 (42%)
Lechien et al. [57]417129 (31%)246 (59%)
Dong et al. [56]112 (18%)1 (9%)
Total: 54Tot: 12,0463085 (25.6%)1866 (15.5%)